HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroaki Kajiyama Selected Research

Biomarkers (Surrogate Marker)

12/2021Placental Leucine Aminopeptidase as a Potential Specific Urine Biomarker for Invasive Ovarian Cancer.
2/2021Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma.
3/2020Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology.
1/2020Long non-coding RNA: A recently accentuated molecule in chemoresistance in cancer.
8/2018Hematopoietic lineage cell-specific protein 1 (HS1), a hidden player in migration, invasion, and tumor formation, is over-expressed in ovarian carcinoma cells.
10/2017A combination of circulating miRNAs for the early detection of ovarian cancer.
3/2014B7-H4 overexpression correlates with a poor prognosis for cervical cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroaki Kajiyama Research Topics

Disease

113Neoplasms (Cancer)
05/2022 - 01/2003
51Carcinoma (Carcinomatosis)
03/2022 - 01/2002
34Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 04/2005
25Ovarian Epithelial Carcinoma
01/2022 - 04/2003
19Neoplasm Metastasis (Metastasis)
04/2022 - 07/2004
18Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2021 - 03/2008
14Endometrial Neoplasms (Endometrial Cancer)
11/2021 - 08/2003
10Choriocarcinoma
01/2022 - 08/2003
9Adenocarcinoma
06/2016 - 01/2003
8Ascites
04/2022 - 11/2007
7Rupture
01/2021 - 01/2009
7Endometrioid Carcinoma
01/2014 - 03/2003
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2020 - 05/2004
5Inflammation (Inflammations)
12/2022 - 01/2016
5Endometriosis
03/2022 - 01/2006
5Glioblastoma (Glioblastoma Multiforme)
01/2021 - 01/2016
5Residual Neoplasm
05/2016 - 10/2011
4Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
04/2021 - 05/2012
4Lymphatic Metastasis
01/2021 - 01/2005
4Teratoma (Teratoid Tumor)
12/2019 - 05/2012
4Mucinous Adenocarcinoma (Mucinous Carcinoma)
03/2019 - 10/2006
3Pre-Eclampsia (Preeclampsia)
12/2022 - 11/2021
3Postpartum Depression (Post-Natal Depression)
07/2022 - 01/2022
3Infertility (Sterility)
02/2022 - 10/2020
3Melanoma (Melanoma, Malignant)
12/2020 - 02/2010
3Lung Neoplasms (Lung Cancer)
01/2020 - 04/2010
3Carcinogenesis
12/2019 - 03/2005
2Hemolysis
12/2022 - 01/2020
2Pulmonary Hypertension
08/2022 - 01/2021
2Leiomyosarcoma
01/2022 - 08/2013

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2003
14Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 11/2004
11EnzymesIBA
12/2022 - 04/2003
11PlatinumIBA
03/2022 - 11/2004
11Cisplatin (Platino)FDA LinkGeneric
01/2022 - 03/2006
11Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
02/2010 - 05/2002
10Peptides (Polypeptides)IBA
01/2022 - 03/2003
10Plasma GasesIBA
01/2021 - 06/2016
10Complementary DNA (cDNA)IBA
11/2009 - 04/2003
8MicroRNAs (MicroRNA)IBA
12/2021 - 08/2014
8Indicators and Reagents (Reagents)IBA
01/2021 - 04/2008
8Small Interfering RNA (siRNA)IBA
05/2020 - 01/2007
8Carboplatin (JM8)FDA LinkGeneric
05/2020 - 11/2004
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2018 - 12/2003
8Angiotensin IIIBA
05/2011 - 08/2003
7Biomarkers (Surrogate Marker)IBA
12/2021 - 03/2014
7ParaffinIBA
12/2019 - 01/2004
6leucyl-cystinyl aminopeptidaseIBA
12/2021 - 04/2003
6Cadherins (E-Cadherin)IBA
01/2020 - 05/2003
5Pharmaceutical PreparationsIBA
01/2022 - 02/2010
5Biological ProductsIBA
03/2021 - 08/2004
5Ringer's LactateIBA
03/2021 - 11/2016
5Formaldehyde (Formol)FDA Link
12/2019 - 01/2004
5Capsules (Microcapsules)IBA
03/2019 - 12/2011
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 05/2016
5GlypicansIBA
09/2014 - 01/2010
4Hormones (Hormone)IBA
01/2022 - 02/2009
4CytokinesIBA
12/2021 - 01/2016
4DNA (Deoxyribonucleic Acid)IBA
07/2021 - 05/2014
4SolutionsIBA
03/2021 - 11/2016
4Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
06/2010 - 04/2008
4Neprilysin (Neutral Endopeptidase)IBA
03/2005 - 04/2003
4Oxytocin (Pitocin)FDA LinkGeneric
08/2004 - 04/2003
3Glucose (Dextrose)FDA LinkGeneric
12/2022 - 01/2007
3taxaneIBA
03/2022 - 10/2011
3AminopeptidasesIBA
01/2022 - 12/2003
3AcidsIBA
06/2021 - 03/2018
3SpectrinIBA
05/2020 - 01/2012
3ChemokinesIBA
01/2020 - 01/2007
3Messenger RNA (mRNA)IBA
03/2018 - 01/2008
3ubenimexIBA
03/2008 - 05/2007
3Chemokine CXCL12IBA
01/2008 - 07/2004
3Endothelin-1 (Endothelin 1)IBA
03/2005 - 08/2004
3Leucyl Aminopeptidase (Peptidase S)IBA
01/2005 - 08/2003
3Glutamyl Aminopeptidase (Aspartyl Aminopeptidase)IBA
08/2004 - 08/2003
3Peptide Hydrolases (Proteases)FDA Link
08/2004 - 05/2004
2LipopolysaccharidesIBA
12/2022 - 01/2021
2Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2022 - 01/2021
2Tuberculin (PPD)IBA
07/2022 - 01/2022
2IronIBA
05/2022 - 10/2020
2Estrogens (Estrogen)FDA Link
03/2022 - 02/2019
2Phosphotransferases (Kinase)IBA
01/2022 - 03/2020
2Polysaccharides (Glycans)IBA
01/2022 - 07/2021
2Vitamin DFDA LinkGeneric
01/2022 - 01/2021

Therapy/Procedure

33Drug Therapy (Chemotherapy)
04/2022 - 11/2004
26Therapeutics
01/2022 - 04/2005
11Lymph Node Excision (Lymph Node Dissection)
01/2022 - 06/2008
9Hysterectomy
11/2021 - 01/2006
6Adjuvant Chemotherapy
03/2022 - 12/2011
5Radiotherapy
05/2019 - 03/2008
4Salpingo-oophorectomy
05/2022 - 01/2006
4Cystectomy
05/2022 - 04/2013
4Chemoradiotherapy
01/2021 - 05/2016
4Cytoreduction Surgical Procedures
01/2019 - 01/2006
3Aftercare (After-Treatment)
01/2022 - 01/2012
3Neoadjuvant Therapy
01/2022 - 01/2004
3Operative Surgical Procedures
12/2021 - 01/2006
3Trachelectomy
11/2021 - 12/2016
3Immunotherapy
10/2021 - 09/2014
2Cesarean Section (Caesarean Section)
05/2022 - 01/2009